University Student Supreme Court to settle Baker et al. v. Frazier without a trial Photo by Helaina-Rose Ball / The Daily Tar Heel By Macie Greene Published Tuesday, June 24, 2025 | Updated 6:19 p.m.

Steelers’ Zach Frazier ‘Excited’ to Work With Aaron Rodgers When the Steelers’ second-year center looks back on the beginning of his NFL career, he could very well be reflecting on a time ...

Sean “Diddy” Combs’s sex-trafficking trial continued on Day 29, when the prosecution and defense rested their cases.

The murder trial of Emmanuel Bedford is underway in South Carolina, with emotional testimony and key evidence presented as prosecutors argue he killed Deidre Reid, a mother who vanished in 2021 ...

A Federal High Court in Abuja has declined a request by the Economic and Financial Crimes Commission (EFCC) to cross-examine its witness in the ongoing trial of alleged money laundering trial of ...

Sean “Diddy” Combs’s federal sex-trafficking trial continued on Day 21 with anonymous witness “Jane” under cross-examination over ‘hotel nights’ and text messages.

Ninety minutes after court was supposed to begin, "Jane" has returned to the witness stand to continue her cross-examination. ‘No Kings’ Rallies Draw Massive Crowds of Anti-Trump Protesters ...

Closing arguments in Sean "Diddy" Combs' sex-trafficking trial begin Thursday in Manhattan. Follow The Post’s live updates for the latest news, evidence photos, reactions and more.

WINSTON-SALEM, N.C. — Day two of a federal redistricting trial has come to a close. It was a long day with even more evidence and data analysis being presented, with the outcome potentially ...

Defense attorney Teny Geragos read messages that appeared to show "Jane," the Sean Combs ex-girlfriend who testified under a pseudonym, arranging sexual encounters with a male escort named Kabrale.

Closing arguments have begun in the Sean “Diddy” Combs trial, as federal prosecutors deliver to the jury an hours-long summary of their case against the disgraced music and fashion mogul.

PMR-116 shows promise in treating MYC-driven cancers, offering hope for patients with aggressive tumors in upcoming human trials.